FMC downgraded at RBC Capital; shares plunge on weak outlook
FMC (NYSE:FMC) on Wednesday was downgraded to Sector Perform from a previous investment rating of Outperform by analysts at ...
RBC Capital Reaffirms Their Hold Rating on NOV (NOV)
In a report released yesterday, Keith Mackey from RBC Capital maintained a Hold rating on NOV (NOV – Research Report), with a price target of ...
RBC Capital Remains a Buy on Xero Limited (XROLF)
RBC Capital analyst Garry Sherriff maintained a Buy rating on Xero Limited (XROLF – Research Report) on February 5 and set a price target of ...
PepsiCo price target lowered to $164 from $172 at RBC Capital
RBC Capital lowered the firm’s price target on PepsiCo (PEP) to $164 from $172 and keeps a Sector Perform rating on the shares. The company reported another “tough quarter” as domestic topline ...
Hosted on MSN1d
RBC Capital Upgrades SSR Mining (SSRM)
Fintel reports that on February 5, 2025, RBC Capital upgraded their outlook for SSR Mining (NasdaqGS:SSRM) from Underperform ...
Hosted on MSN1d
RBC Capital Downgrades FMC (FMC)
Fintel reports that on February 5, 2025, RBC Capital downgraded their outlook for FMC (NYSE:FMC) from Outperform to Sector ...
Biggest of the Big Six: How RBC opened a $100-billion market-cap gap over its banking rivals
J.M. Smucker Co. chief executive Mark Smucker leaned on close advisers when he made the decision to bolster the jelly and ...
Sarepta could be down on patient death in FDA database, says RBC Capital
RBC Capital analyst Brian Abrahams says shares of Sarepta (SRPT) could be trading lower today on an FDA database update that ...
Alliance Pharma downgraded by RBC after weak H2, revenue miss
The downgrade comes after the company reported full-year revenue that fell 4% below market expectations, reflecting an underperformance in the second half of the year.